Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Experts debate the ‘myth’ of metabolically healthy obesity
-
- Quality improvement interventions needed to advance diabetes care
- Experts debate statin acceleration of type 2 diabetes development
- To make a difference, adrenal cancer requires research and advocacy collaboration Gary D. Hammer, MD, PhD
- Hyperthyroidism and a thyroid nodule Stephanie L. Lee, MD, PhD, ECNU
- 17-beta estradiol involved in down-regulation of TRAIL, CV health
- ACCORD MIND: Intensive BP therapy failed to lower cognitive decline in diabetes
- Chronic villous atrophy increased hip fracture risk in celiac disease
- Complex treatments, diabetes insipidus predicted complications in childhood-onset craniopharyngioma
-
- CV risk elevated in patients with adrenal incidentalomas, mild hypercortisolism
- Diabetes diagnosis in one spouse may increase risk in other
- Early infant weight gain increased NAFLD risk in adulthood
- Increased solutes led to ESRD in type 2 diabetes
- Less than three metabolic risk factors found in majority of patients with abdominal obesity
- Serotonin receptor shows promise in hypoactive sexual desire disorder
- Stellate ganglion blockade may be alternative to HT for vasomotor symptoms
- Teriparatide increased BMD, bone strength in mild osteogenesis imperfecta
-
- Two studies examine metabolic adaptations to SGLT2 inhibitors
- Vitamin D may decrease PTH without increasing blood, urinary calcium
- Moderate physical activity may compensate for hormone therapy stroke risk
- Radiotherapy plus hormone therapy halved prostate cancer mortality
- Guidelines suggest more aggressive initial treatment of type 2 diabetes James R. Taylor, PharmD, CDE